Sandoz Group AG (SDZXF)

Market Cap	33.82B +73.4%
Revenue (ttm)	10.59B +4.7%
Net Income	227.00M
EPS	0.52
Shares Out	n/a
PE Ratio	148.99
Forward PE	20.75
Dividend	0.73 (0.94%)
Ex-Dividend Date	Apr 17, 2025

Volume	51,988
Average Volume	2,891
Open	78.66
Previous Close	76.75
Day's Range	78.66 - 78.66
52-Week Range	36.68 - 82.27
Beta	0.25
RSI	69.47
Earnings Date	Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1886
• Employees: 20,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: SDZXF